EP3795584A1 Recombinant Bovine FSH Hormone for Bovine Superovulation and Estrus Synchronization, April 15, 2026
Summary
The EPO published patent application EP3795584A1 for a recombinant bovine follicle-stimulating hormone (FSH) composition and its use in inducing superovulation and estrus synchronization in bovines. The application names Centro de Biotecnología y Biomedicina SPA and Fundaçao Edson Quiroz - Universidad de Fortaleza as applicants, with ten listed inventors including Sanchez Ramos, Toledo Alonso, and Hugues Salazar. The filing is classified under IPC C07K 14/59 (peptides) and A61K 38/24 (pharmaceutical preparations), with designation covering all EPO member states including DE, FR, GB, IT, NL, ES, and 25 others.
About this source
GovPing monitors EPO Patent Bulletin - Peptides (C07K) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 34 changes logged to date.
What changed
The EPO published patent application EP3795584A1 disclosing a recombinant bovine FSH hormone, a composition containing said hormone, and methods for inducing superovulation and estrus synchronization in bovine subjects. The application claims priority from an earlier filing and names ten individual inventors across two institutions based in Chile and Brazil.
For parties seeking to develop or commercialise recombinant FSH products for veterinary use in Europe, this publication establishes a visible IP landscape in the bovine superovulation space. Potential competitors should review the application's claims and designated states when planning product launches in EPO member territories.
Archived snapshot
Apr 23, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
RECOMBINANT BOVINE FOLLICLE-STIMULATING HORMONE, COMPOSITION COMPRISING THE SAME, AND METHOD TO INDUCE SUPEROVULATION AND ESTRUS SYNCHRONIZATION IN BOVINES USING SAID HORMONE
Publication EP3795584A1 Kind: A1 Apr 15, 2026
Applicants
Centro de Biotecnología y Biomedicina SPA, Fundaçao Edson Quiroz - Universidad de Fortaleza
Inventors
SANCHEZ RAMOS, Oliberto, TOLEDO ALONSO, Jorge, HUGUES SALAZAR, Florence, CABEZAS ÁVILA, Ignacio, CERRO GARRIDO, Rita Paulina, PARRA PEREIRA, Natalie Carolina, ACOSTA ALBA, Jannel, SIMIANO TAVARES, Kaio Cesar, TONDELLO MARTINS, Leonardo, GAUDENCIO NETO, Saul
IPC Classifications
C07K 14/59 20060101AFI20191122BHEP A61K 38/24 20060101ALI20191122BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Named provisions
Parties
Related changes
Get daily alerts for EPO Patent Bulletin - Peptides (C07K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Peptides (C07K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.